Zomedica Corp.
ZOMDF
$0.041
$0.00194.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.59% | 3.80% | 7.61% | 10.24% | 1.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.59% | 3.80% | 7.61% | 10.24% | 1.84% |
| Cost of Revenue | 29.90% | -2.42% | 3.67% | -2.42% | -10.29% |
| Gross Profit | 6.97% | 7.04% | 9.36% | 16.00% | 7.76% |
| SG&A Expenses | -9.11% | -11.49% | -13.48% | 12.83% | 19.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.15% | -8.61% | -14.26% | 17.42% | 18.90% |
| Operating Income | 11.15% | 16.09% | 28.35% | -25.08% | -34.13% |
| Income Before Tax | 69.32% | -584.82% | 66.21% | -178.89% | -352.01% |
| Income Tax Expenses | 108.39% | 65.66% | -148.15% | 98.59% | -85.71% |
| Earnings from Continuing Operations | 69.09% | -596.60% | 67.89% | -1,263.95% | -355.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.09% | -596.60% | 67.89% | -1,263.95% | -355.92% |
| EBIT | 11.15% | 16.09% | 28.35% | -25.08% | -34.13% |
| EBITDA | 13.47% | 23.11% | 35.81% | -24.36% | -34.00% |
| EPS Basic | 69.26% | -600.00% | 68.12% | -1,260.00% | -351.85% |
| Normalized Basic EPS | 7.84% | 15.00% | 28.79% | -44.83% | -50.00% |
| EPS Diluted | 69.26% | -600.00% | 27.07% | -1,260.00% | -351.85% |
| Normalized Diluted EPS | 7.84% | 15.00% | 28.79% | -44.83% | -50.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |